We're not getting any younger... yet.
Why do some of us age gracefully and others don’t? How do our bodies and minds experience aging at the cellular and molecular level? Why do we even age to begin with? And maybe most importantly, can we do anything about it? Join hosts Eric Verdin, CEO of the Buck Institute in California, and Brianna Stubbs, Director of Translational Science at the Buck, as they speak with some of the brightest scientific stars on the planet to search for – and actually find answers to – these questions and many more.
We're not getting any younger... yet.
Andrea Maier: From Potential to Practice
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
The movement to integrate longevity treatments into clinical care is making strides. How can we ensure they are evidence-based, accessible, and personalized? World-renowned geroscientist Andrea Maier has been leading the way with innovative clinical trials and cutting edge research. In this episode, she talks with Gordon about the current state of the field, why we need a variety of clocks and interventions, what we can all do now to age better, and what the future of clinical practice looks like.
Professor Andrea Maier is a prolific researcher in the field of geroscience — the intersection of aging biology, chronic disease, and health. A principal investigator in gerontology, as well as a specialist in internal medicine and geriatrics, Professor Maier's aging research focuses on age-related diseases, cellular senescence and the translation of results into clinical practice. She has published almost 400 peer-reviewed articles and has spearheaded significant contributions of her highly acclaimed innovative, global, multidisciplinary work with her @Age Research Group. Professor Maier holds professorship appointments at VU University Medical Centre, Amsterdam, Netherlands and University of Melbourne, Australia. Professor Maier is the past President of the Australia and New Zealand Society for Sarcopenia and Frailty Research and founding president of the Healthy Longevity Medicine Society. She sits on several prestigious international academic and health policy committees and organizations, including national and international research funding agencies and the World Health Organization.
